Rochester General Health System
Hematology Research
Helping you manage your blood disease
At Rochester General Hospital and the Mary M. Gooley Hemophilia Center, we’re committed to treating patients with leading-edge medical care while attending to the personal needs of patients and their families. That same level of care extends to our hematology research department, where we continually seek more effective ways of treating:
- Hemochromatosis, a genetic disease marked by the buildup of iron in the body.
- Clotting disorders such as hemophilia and von Willebrand disease (VWD).
- Bleeding abnormalities in pregnant and menstruating women.
The work of our physicians, who are hematologists/oncologists at RGH’s Lipson Cancer and Blood Center, frequently overlaps that of medical oncology, in the study of lymphoma and leukemia.
Patients who volunteer for clinical trials in hematology and hemophilia may benefit from receiving an investigational treatment before it’s widely available. For those suffering from the diseases we treat, participation in a trial can bring renewed hope and a greater sense of control.
Most of our clinical trials are conducted with patients already in the RGH system, but we occasionally recruit from the community. For information on hematology clinical trials, contact Laura Braggins, research manager at the Mary M. Gooley Hemophilia Center, at (585) 922-5006.
The Hemophilia Center is a private, not-for-profit organization that works closely with RGH. For hemophilia information, please visit www.hemocenter.org.
Search Clinical Trials
Frequently Asked Questions
Related Video
Quality Care, Exceptional Service Hear what our team members have to say about Rochester General Health System.
